New Look Vision Group Inc. (BCI.TO)

Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research. Company has managed COVID well overall. Consolidator; maintains dominance in Canada. Expensive valuation relative to history. Dividend suspended.

Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research. Company has managed COVID well overall. Consolidator; maintains dominance in Canada. Expensive valuation relative to history.

(A Top Pick Jan 27/20, Up 16%) Tough couple of quarters during Covid. Strong management, cut costs. Last quarter, pretty strong EBITDA numbers. A consolidator, so might do future acquisitions.

(A Top Pick Dec 26/20, Up 11%) He would buy it again. As things have re-opened, the demand has come back.

It is a tightly held stock, not well known. It is a leading eye care operator in Canada. They grew significantly over time to 379 locations across Canada. They made a small acquisition in the US in the luxury eye care segment. It is recession resistant and benefits from the aging demographic. It has a strong management team and he thinks it has a big growth runway as they consolidate a fragmented eye care industry. (Analysts’ price target is $42.00)